Fras-le S.A. (BVMF:FRAS3)

Sage Therapeutics Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	713.07	844.88	1,050	567.86	363.6	443.24
Short-Term Investments	-	549.47	0.05	-	0.06	19.64
Trading Asset Securities	7.53	-	-	494.13	-	-
Cash & Short-Term Investments	720.6	1,394	1,050	1,062	363.66	462.88
Cash Growth	-42.00%	32.74%	-1.08%	192.03%	-21.44%	116.84%
Accounts Receivable	661.51	433.63	420.66	271.68	268.01	289.19
Other Receivables	225.65	143.38	88.9	98	123.45	171.97
Receivables	887.17	577.01	509.56	369.68	391.46	461.16
Inventory	1,676	1,055	783.47	857.67	825.23	494.1
Other Current Assets	0.09	51.98	29.14	-	31.65	28.83
Total Current Assets	3,284	3,078	2,373	2,289	1,612	1,447
Property, Plant & Equipment	1,275	914.84	803.57	794.47	812.13	733.46
Long-Term Investments	197.21	141.65	71.19	66.42	59.5	68.88
Goodwill	-	193.56	184.27	151.34	151.34	156.29
Other Intangible Assets	1,822	393.3	370.29	322.8	347.42	349.69
Long-Term Deferred Tax Assets	-	-	1.96	16.1	2.91	-
Other Long-Term Assets	157.28	148.17	108.09	125.41	97.03	86.61
Total Assets	6,735	4,870	3,912	3,766	3,082	2,842
Accounts Payable	622.11	612.18	414.34	385.63	310.07	265.4
Accrued Expenses	117.9	113.71	93.25	171.81	87.76	61.74
Short-Term Debt	32.48	23.82	32.56	14.27	67.8	43.4
Current Portion of Long-Term Debt	376.33	369.8	293.78	154.31	164.73	180.78
Current Portion of Leases	37.88	24.09	16.85	15.18	12.38	16.78
Current Income Taxes Payable	130.51	140.9	106.56	5.71	64.46	78.21
Other Current Liabilities	184.21	214.73	155.99	115.22	118.32	172.13
Total Current Liabilities	1,501	1,499	1,113	862.13	825.52	818.44
Long-Term Debt	2,343	728.46	579.52	762.24	786.89	702.43
Long-Term Leases	211.93	148.18	138.13	134.47	143.91	128.86
Long-Term Unearned Revenue	1.48	1.48	1.48	1.74	2.01	2.28
Long-Term Deferred Tax Liabilities	155.14	8.72	-	-	-	5.31
Other Long-Term Liabilities	358.06	232.08	218.44	226.87	218.04	229.78
Total Liabilities	4,571	2,618	2,051	1,987	1,976	1,887
Common Stock	1,229	1,229	1,229	1,229	600	600
Retained Earnings	1,115	1,047	852.5	600.51	474.82	327.65
Treasury Stock	-13.35	-13.35	-13.35	-13.35	-13.35	-13.35
Comprehensive Income & Other	-199.95	-44.55	-230.36	-52.65	34.11	29.53
Total Common Equity	2,131	2,219	1,838	1,764	1,096	943.83
Minority Interest	33.08	32.64	22.93	14.54	10.39	10.98
Shareholders' Equity	2,164	2,251	1,861	1,778	1,106	954.81
Total Liabilities & Equity	6,735	4,870	3,912	3,766	3,082	2,842
Total Debt	3,001	1,294	1,061	1,080	1,176	1,072
Net Cash (Debt)	-2,281	100.01	-10.37	-18.47	-812.05	-609.36
Net Cash Per Share	-8.54	0.37	-0.04	-0.07	-3.78	-2.84
Filing Date Shares Outstanding	267.02	267.02	267.02	267.02	214.57	214.57
Total Common Shares Outstanding	267.02	267.02	267.02	267.02	214.57	214.57
Working Capital	1,783	1,579	1,259	1,427	786.47	628.54
Book Value Per Share	7.98	8.31	6.88	6.61	5.11	4.40
Tangible Book Value	309.36	1,632	1,284	1,290	596.81	437.85
Tangible Book Value Per Share	1.16	6.11	4.81	4.83	2.78	2.04
Land	-	228.96	236.2	233.36	231.99	252.01
Machinery	-	1,293	1,169	1,117	1,093	990.28
Construction In Progress	-	127.4	67.73	69.03	61.91	65.04

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.